clopidogrel has been researched along with Coronary Stenosis in 141 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 90 (63.83) | 29.6817 |
2010's | 48 (34.04) | 24.3611 |
2020's | 3 (2.13) | 2.80 |
Authors | Studies |
---|---|
Intini, A; Sahadevan, J; Tsushima, T | 1 |
Alam, M; Bandeali, S; Chan, PS; Hamzeh, I; Hira, R; Jones, PG; Khalid, U; Kleiman, NS; Lakkis, N; Virani, SS | 1 |
Athurupana, AASD; Bowatte, PGCS; Dissanayake, WP; Ehelepola, NDB | 1 |
Bocchino, PP; D'Ascenzo, F; De Ferrari, GM; De Filippo, O; Imazio, M; Piroli, F; Scacciatella, P | 1 |
Haruta, H; Hirayama, A; Hiro, T; Kitano, D; Kurosawa, T; Li, Y; Matsumoto, T; Migita, S; Mitsumata, M; Okumura, Y; Sudo, M; Takahashi, R; Takayama, T; Taniguchi, Y | 1 |
Cho, JY; Hong, SJ; Joo, HJ; Kim, KA; Lee, SH; Lim, DS; Park, JH; Park, JY; Yu, CW | 1 |
Fujimoto, W; Kawai, H; Miyata, T; Oishi, S; Onishi, T; Osue, T; Sawada, T; Shimane, A; Takahashi, Y; Takaya, T; Taniguchi, Y; Toba, T; Yasaka, Y | 1 |
Janus, M; Lesiak, M; Lukawski, K; Prech, M | 1 |
Gurbel, PA; Tantry, US | 1 |
Emanuelsson, H; Gibson, CM; Harrington, RA; Horrow, J; James, SK; Katus, H; Kunadian, V; Maya, J; Steg, PG; Storey, RF; Wallentin, L; Wojdyla, DM; Wu, J; Zorkun, C | 1 |
Brodie, BR; Cox, DA; Duffy, PL; Gurbel, PA; Henry, TD; Kirtane, AJ; Mazzaferri, E; Mehran, R; Metzger, DC; Neumann, FJ; Parise, H; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Xu, K | 1 |
Limbruno, U; Musumeci, G | 1 |
de Groot, PG; Hillaert, MA; Pasterkamp, G; Pijls, NH; Roest, M; Rutten, B; Sels, JW; van Holten, TC; Waltenberger, J | 1 |
Er Ching, M; Ho, HH; Ong, PJ; Ooi, YW | 1 |
Chen, F; Loh, JP; Omar, A; Pendyala, LK; Pichard, AD; Satler, LF; Torguson, R; Waksman, R | 1 |
Fujikawa, T; Fukuyama, K; Kuramitsu, S; Tanaka, A | 1 |
Abdel-Wahab, M; Anette Fiedler, K; Gershlick, AH; Hoppmann, P; Ibrahim, T; Kastrati, A; Kufner, S; Laugwitz, KL; Mehilli, J; Mehran, R; Morath, T; Neudecker, J; Richardt, G; Schneider, S; Schulz, S; Schunkert, H; Tölg, R | 1 |
Alfonso Manterola, F; Doncel Vecino, LJ; Fernández Díaz, JA; Fernández Portales, J; González Fernández, R; López Mínguez, JR; Martínez Cáceres, G; Martínez Romero, P; Merchán Herrera, A; Nogales Asensio, JM; Romany, S; Sandoval, J | 1 |
Al-Atassi, T; Kulik, A; Le May, M; Ruel, M; Une, D; Voisine, P | 1 |
Akasaka, T; Hanawa, K; Hao, K; Hasebe, Y; Hirano, M; Ito, K; Matsumoto, Y; Miyata, S; Nishimiya, K; Ogata, T; Oyama, K; Shimokawa, H; Shindo, T; Takahashi, J; Tanaka, A; Taruya, A; Tsuburaya, R; Uzuka, H | 1 |
Bai, X; Fang, Q; Ni, J; Tang, J; Xu, J; Yang, M; Zeng, Y | 1 |
Al-Hawwas, M; Azzalini, L; L'Allier, PL | 1 |
Chan, KH; Chan, MY; Lee, CH; Low, AF; Richards, AM; Sethi, R; Shi, H; Tan, HC; Teo, SG | 1 |
Blackman, D; Curzen, N; Dalby, M; Flather, M; Gershlick, AH; Greenwood, JP; Hetherington, S; Kelly, DJ; Khan, JN; Lai, FY; McCann, GP; Nazir, SA; Peebles, C; Swanton, H; Wong, J | 1 |
Gwon, HC; Han, KR; Hur, SH; Jeong, MH; Kim, HS; Koo, BK; Park, JS; Park, KW; Park, SJ; Rha, SW; Seo, JB; Seong, IW; Shin, DH; Tahk, SJ; Yang, JY; Yoon, JH | 1 |
Cho, MH; Kim, EH; Kim, HK; Lee, H; Lee, SP; Lim, YK; Shin, DW; Shin, JH; Yun, JM | 1 |
Bae, JW; Hur, SH; Jeon, DW; Kim, BS; Kim, HS; Koo, BK; Lee, H; Lee, JH; Lee, NH; Lim, SW; Oh, SK; Park, KW; Park, TH; Rha, SW; Shin, ES | 1 |
Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH | 1 |
Cohn, WE; Cooley, DA; de la Cruz, KI; Tsai, PI | 1 |
Barthwal, R; Herman, BA | 1 |
Aradi, D; Komócsi, A; Vorobcsuk, A | 1 |
Farhan, S; Glogar, D; Gyöngyösi, M; Hemetsberger, H; Hemetsberger, R; Huber, K; Pavo, I; Petrasi, Z; Posa, A; Sperker, W; Strehblow, C | 1 |
Christ, G; Jilma, B; Lang, I; Siller-Matula, JM | 1 |
Kleiman, NS | 1 |
Akao, M; Doi, T; Furukawa, Y; Horiuchi, H; Hoshino, K; Ikeda, T; Jinnai, T; Kawato, M; Kimura, T; Kita, T; Morimoto, T; Nishi, E; Nishimoto, N; Ouchi, C; Ozasa, N; Saito, N; Shizuta, S; Tada, T; Takahashi, K; Tamura, T; Tazaki, J; Toma, M; Watanabe, H; Yamamoto, H; Yoshikawa, Y | 1 |
Cho, EJ; Her, SH; Jang, SW; Kim, DB; Kim, JH; Kwon, BJ; Park, CS; Park, HJ; Park, MW; Rho, TH; Shin, D | 1 |
Hussein, A; Irani, F; Kasmani, R; Mohan, G | 1 |
Ajani, AE; Andrianopoulos, N; Black, A; Brennan, A; Butler, MJ; Clark, DJ; Dart, AM; Duffy, SJ; Eccleston, D; New, G; Reid, CM; Shaw, JA; Szto, G; Yan, BP | 1 |
Angiolillo, DJ; Brugaletta, S; Campos, B; Cola, C; Martín Yuste, V; Sabaté, M | 1 |
Gao, C; Li, D; Li, L; Ren, C | 1 |
Chung, HS; Kim, JH; Kwon, TH; Moon, HJ; Park, YK | 1 |
Cohen, GN; Fawzy, HF; Fremes, SE; Goldman, BE; Laflamme, C; Nesher, N; Sever, JY; Singh, SK | 1 |
Antonijević, N; Antović, J; Baskot, B; Djenić, N; Dopudja, M; Gligić, B; Grdenić, A; Jovelić, A; Miković, D; Obradović, S; Salinger, S; Subota, V; Vukotić, S | 1 |
Coolong, A; Kereiakes, DJ; Mauri, L; Naidu, SS; Popma, JJ; Turco, MA | 1 |
Bestehorn, HP; Büttner, HJ; Fromm, MF; Hochholzer, W; Neumann, FJ; Stratz, C; Trenk, D; Valina, CM | 1 |
Barbato, E; D'Ambrosio, A; Di Sciascio, G; Gatto, L; Mangiacapra, F; Muller, O; Patti, G; Peace, A; Ricottini, E; Vizzi, V | 1 |
Behnia, M; Brieger, D; Chang, M; Chung, T; Hamzah, A; Krilis, SA; Kritharides, L; Lowe, HC; Ng, MK; Pennings, GJ; Qi, M; Yong, AS | 1 |
Cho, BR; Choi, JH; Choi, SH; Gwon, HC; Hahn, JY; Han, KR; Hur, SH; Lee, S; Lee, SH; Lee, SY; Lim, DS; Park, HS; Park, JS; Rha, SW; Song, YB; Yoon, J | 1 |
Brodoefel, H; Burgstahler, C; Drosch, T; Geisler, T; Heuschmid, M; Quell, V; Reimann, A; Schroeder, S | 1 |
Byron, KA; Dear, AE; Dick, RJ | 1 |
Caillard, S; Campia, U; El Ghannudi, S; Gachet, C; Jesel, L; Meyer, N; Morel, O; Moulin, B; Ohlmann, P; Radulescu, B; Wiesel, ML | 1 |
Egred, M | 1 |
Cosentino, N; Crea, F; Minelli, S; Niccoli, G | 1 |
Aradi, D; Komócsi, A; Kovács, GL; Magyarlaki, T; Miseta, A; Rideg, O; Tokés-Füzesi, M | 1 |
Cho, HJ; Jeon, KH; Kang, HJ; Kang, SH; Kim, HS; Koo, BK; Lee, HY; Oh, BH; Oh, IY; Park, KW; Park, SK; Park, YB | 1 |
Ilic, I; Neskovic, AN; Putnikovic, B; Stankovic, I; Vlahovic-Stipac, A | 1 |
Biondi-Zoccai, G; Bramucci, E; Colombo, A; Ferlini, M; Grinfeld, L; Iadanza, A; Morice, MC; Petronio, AS; Pierli, C; Sangiorgi, GM | 1 |
Abegunewardene, N; Gori, T; Horstick, G; Kreitner, KF; Lehr, HA; Münzel, T; Schmidt, KH; Schreiber, LM; Vosseler, M | 1 |
Ando, J; Fujita, H; Morita, H; Nagai, R; Nakayama, A; Ohtsu, H | 1 |
Atalar, E; Canpolat, U; Yorgun, H | 1 |
Lacasa, RC; Linares Vicente, JA; Pérez, JO | 1 |
Witzenbichler, B | 1 |
Ho, HH; Jafary, FH; Loh, KK; Ong, PJ; Ooi, YW; Tan, JK | 1 |
Can, MM; Dinicolantonio, JJ; Goto, S; Serebruany, VL | 1 |
Silber, S | 1 |
Barragan, P; Bouvier, JL; Camoin, L; Comet, B; Commeau, P; Eigenthaler, M; Lafont, A; Macaluso, G; Roquebert, PO; Walter, U | 1 |
Albirini, A; Aronow, HD; Bhatt, DL; Cura, FA; Ellis, SG; L'Allier, PL; Schneider, JP; Topol, EJ | 1 |
Beygui, F; Elalamy, I; Helft, G; Khellaf, C; Laudy, C; Le Feuvre, C; Metzger, JP; Monnet de Lorbeau, B; Ounissi, F; Tran, D | 1 |
Ali-Hasan, S; Gaitonde, RS; Jayachandran, JV; Kalaria, VG; Miller, JM; Sharma, N | 1 |
Gershlick, AH; Khambekar, SK; Kovac, J | 1 |
Colombo, A; Desmedt, B; Di Mario, C; Holmes, DR; Leon, MB; Louvard, Y; Ludwig, J; Morice, MC; Moses, JW; Spanos, V | 1 |
Hirmerova, J; Moll, S; Napoli, M; Ohman, EM; Rubery, B; Simpson, R; Stouffer, GA | 1 |
Fernandes, C; Hopkins, AP; Juergens, CP; Leung, DY; Lo, S; Lowe, HC; Newland, EF; Wong, AM | 1 |
Berger, PB | 1 |
Angiolillo, DJ; Bernardo, E; Jiménez-Quevedo, P; Sabaté, M | 1 |
Ajani, AE; Waksman, R | 1 |
Alfonso, F; Angiolillo, DJ; Barrera Ramírez, C; Bernardo, E; Escaned, J; Fernandez, C; Fernández-Ortiz, A; Hernández-Antolín, R; Macaya, C; Sabaté, M | 1 |
Patel, MR; Peterson, ED | 1 |
Bachinsky, W; Bass, T; DeMaio, S; Fry, E; Holmes, DR; Kuntz, RE; Leon, MB; Moses, JW; Popma, JJ; Sawhney, N; Teirstein, PS | 1 |
Casselman, FP; Dom, H; Foubert, L; Meco, M; Van Praet, F; Vanermen, H | 1 |
Akbulut, M; Arslan, N; Gundogdu, O; Ilkay, E; Karaca, I; Ozbay, Y | 1 |
Block, M; Rampp, T | 1 |
Berger, P; Grines, C; Harrington, RA; Ohman, EM; Popma, JJ; Weitz, JI | 1 |
Choudhury, A; Fisher, E; Kim, MC; Kini, AS; Lee, J; Sharma, SK; Steinheimer, AM | 1 |
Berger, PB; Hennekens, CH; Lowry, DR; Malinin, AI; Midei, MG; O'Connor, CM; Oshrine, BR; Sane, DC; Serebruany, VL; Steinhubl, SR; Tanguay, JF | 1 |
Cox, N; Douglas, J; Fitzpatrick, M; Holmes, DR; Kuntz, RE; Lambert, C; Leon, MB; Mooney, M; Moses, JW; Popma, JJ; Yakubov, S | 1 |
Bauersachs, J; Bonz, A; Ertl, G; Grossmann, R; Obergfell, A; Strotmann, J; Walter, U | 1 |
Eich, A; Münzel, T; von Mach, MA; Weilemann, LS | 1 |
Bliden, KP; Gurbel, PA; Hayes, KM; Tantry, US; Yoho, JA; Zaman, KA | 1 |
Antman, EM; Leopold, JA | 1 |
Bliden, KP; Gurbel, PA; Hayes, KM; Herzog, WR; Tantry, US; Yoho, JA | 1 |
Aranki, S; Bhatia, D; Bhatt, DL; Byrne, J; Mehta, S; Mills, R | 1 |
Kunz, I; Ruggieri, F; Spada, S; Sütsch, G | 1 |
Karvouni, E; Katritsis, DG; Korovesis, S | 1 |
Bazemore, E; Jobe, RL; Mann, T; Schneider, JE; Wood, F | 1 |
Agostoni, P; Airoldi, F; Barbagallo, R; Biondi-Zoccai, GG; Briguori, C; Carlino, M; Chieffo, A; Colombo, A; Falchetti, E; Iakovou, I; Margheri, M; Melzi, G; Michev, I; Montorfano, M; Remigi, E; Sangiorgi, GM; Tamburino, C; Tsagalou, E; Vittori, G | 1 |
Castelvetri, C; Cosmi, B; Milandri, M; Rubboli, A | 1 |
Cay, S; Korkmaz, S; Yilmaz, MB | 1 |
Baum, H; Braun, S; Dibra, A; Dirschinger, J; Hadamitzky, M; Kastrati, A; Mehilli, J; Schömig, A; Schühlen, H | 1 |
Biancari, F; Juvonen, T | 1 |
Bliden, KP; Gurbel, PA; Tantry, US | 1 |
Lengyel, M | 1 |
Bliden, KP; Fissha, MZ; Gurbel, PA; Hayes, K; Samara, W; Tantry, US; Yoho, JA | 1 |
Berge, C; Deme, M; Gershlick, AH; Guagliumi, G; Guyon, P; Lotan, C; Schofer, J; Seth, A; Sousa, JE; Stoll, HP; Urban, P; Wijns, W | 1 |
Hocking, WG; Rezkalla, SH; Vats, HS | 1 |
Drexler, H; Schaefer, A; Stumme, B; Templin, C; von Depka, M | 1 |
Holzhausen, C; Ince, H; Körber, T; Nienaber, CA; Rehders, T; Schneider, H; Weber, F | 1 |
Avsar, A; Celik, A; Kaya, D | 1 |
Aggarwal, N; Bliden, KP; Gurbel, PA; Guyer, K; Tantry, US | 1 |
Bozios, G; Kalef-Ezra, J; Katsouras, CS; Kotsia, A; Michalis, LK; Naka, KK; Nikas, DN; Papamichael, N; Pappas, C; Sideris, DA; Tsekeris, P | 1 |
Borgdorff, P; Paulus, WJ; Tangelder, GJ | 1 |
Founztopoulous, E; Gunning, MG; Mavroudis, C; Nadar, SK | 1 |
Ling, F; Wang, N; Xu, J; Yang, J; Ye, X; Zhang, X; Zhou, L | 1 |
Karpha, M; Lip, GY | 1 |
Bader, F; Brunner-La Rocca, HP; Buser, PT; Hunziker, P; Jeger, R; Kaiser, C; Mueller, C; Osswald, S; Pfisterer, M; Rickenbacher, P | 1 |
Califf, RM; Harrington, RA | 1 |
Berry, C; Bonan, R; Dorval, JF; Soulez, G | 1 |
Cohen, MG; Dunn, SP; Lee, JS; Marshall, HM; Smyth, SS | 1 |
Alfonso, F; Angiolillo, DJ; Bañuelos, C; Escaned, J; Fernández, C; Fernández-Avilés, F; Gómez-Hospital, JA; Hernández-Antolín, R; Jiménez-Quevedo, P; Macaya, C; Moreno, R; Sabaté, M; SanMartín, M | 1 |
Aurier, E; Benassi, A; Cremonesi, A; Grilli, R; Guastaroba, P; Magnavacchi, P; Manari, A; Maresta, A; Marzocchi, A; Percoco, G; Piovaccari, G; Saia, F; Varani, E | 1 |
Belli, G; Presbitero, P; Rossi, M; Zavalloni, D | 1 |
Harish, CR; Satish, B; Tressa, K | 1 |
Knapp, M; Musiał, WJ; Prokop, JB; Sawicki, R; Sobkowicz, B; Tomaszuk-Kazberuk, A; Usowicz-Szaryńska, M | 1 |
Chi, HS; Hong, MK; Jang, S; Kim, JJ; Kim, YH; Lee, BK; Lee, CW; Lee, SW; Park, DW; Park, SJ; Park, SW | 1 |
Campo, G; Catozzi, L; Federici, F; Ferrari, F; Ferrari, R; Frangione, A; Gemmati, D; Luccarelli, S; Parrinello, G; Percoco, G; Tebaldi, M; Valgimigli, M | 1 |
Nisanci, Y; Okcular, I; Sezer, M; Umman, B; Umman, S | 1 |
Abbate, A; Agostoni, P; Alessi, MC; Angiolillo, DJ; Biondi-Zoccai, GG; Collet, JP; Cuisset, T; Di Sciascio, G; Laudito, A; Lotrionte, M; Meliga, E; Montalescot, G; Moretti, C; Sangiorgi, G; Sheiban, I; Testa, L; Trevi, GP; Valgimigli, M; Waksman, R | 1 |
de Korte, FI; Ten Berg, JM; van Werkum, JW; Vijverberg, PL | 1 |
Badenhorst, PN; Brown, S; Bruwer, A; De Meyer, SF; Deckmyn, H; Janssens, S; Lamprecht, S; Meiring, M; Pieters, H; Roodt, J; Staelens, S; Vanhoorelbeke, K | 1 |
Bruschi, G; Colombo, P; Colombo, T; Piccalò, G; Trunfio, S; Vitali, E | 1 |
Endemann, S; Ernst, A; Gollapudi, RR; Levisay, JP; Price, MJ; Sawhney, NS; Schatz, RA; Stinis, CT; Teirstein, PS; Valencia, R | 1 |
Serebruany, VL | 1 |
Assali, A; Battler, A; Brosh, D; Fuchs, S; Kornowski, R; Lev, EI; Vaknin-Assa, H | 1 |
Holmes, DR | 1 |
Gawaz, M; Geisler, T; Paterok, M; Zürn, CS | 1 |
Bigalke, B; Dippon, J; Gawaz, M; Geisler, T; Göhring-Frischholz, K; Herdeg, C; Kraemer, BF; May, AE; Paterok, M; Seizer, P; Stellos, K; Zürn, C | 1 |
Bhargava, B; Kent, KM; Kim, HS; Kollum, M; Kolodgie, FD; Mintz, GS; Virmani, R; Waksman, R | 1 |
Chesterman, CN; Fahmy, RG; Khachigian, LM; Kumar, RK; Lowe, HC | 1 |
Driscoll, E; Hasa, AA; Lucchesi, BR; Normolle, D; Schmaier, AH; Warnock, M; Werns, SW | 1 |
Amornsak, N; Chatlaong, B; Intayakorn, U; Laothavorn, P; Leelaprute, M; Nasawadi, C; Piamsomboon, C; Saguanwong, S; Tanprasert, P | 1 |
9 review(s) available for clopidogrel and Coronary Stenosis
Article | Year |
---|---|
Syncope After Percutaneous Coronary Intervention.
Topics: Clopidogrel; Coronary Artery Bypass; Coronary Stenosis; Drug Substitution; Drug-Eluting Stents; Electrocardiography; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Postoperative Care; Postoperative Complications; Syncope; Ticagrelor; Time Factors; Treatment Outcome | 2019 |
Revascularization treatment recommendations based on atherosclerotic disease distribution: coronary artery bypass grafting versus stenting.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Diabetic Angiopathies; Drug-Eluting Stents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Reoperation; Stents; Ticlopidine; Treatment Outcome | 2008 |
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Female; Humans; Medication Adherence; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Ticlopidine; Treatment Outcome | 2009 |
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Contraindications; Coronary Restenosis; Coronary Stenosis; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Hirudins; Humans; Immunoglobulin Fab Fragments; Peptide Fragments; Practice Guidelines as Topic; Pyridines; Recombinant Proteins; Risk Assessment; Stents; Ticlopidine | 2004 |
Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary Stenosis; Female; Humans; Male; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prognosis; Radiography; Risk Assessment; Stents; Survival Rate; Ticlopidine; Treatment Outcome | 2005 |
Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting.
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Stenosis; Drug Therapy, Combination; Follow-Up Studies; Humans; Long-Term Care; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Ticlopidine; Treatment Outcome | 2005 |
[Triplex antithrombotic therapy after coronary-stent implantation (that is absent from recommendation)].
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Coumarins; Drug Therapy, Combination; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Secondary Prevention; Stents; Ticlopidine | 2005 |
[Dual antithrombotic therapy after implantation of coronary stents].
Topics: Aspirin; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Synergism; Humans; Platelet Aggregation Inhibitors; Stents; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2006 |
Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Drug Administration Schedule; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Ticlopidine | 2007 |
27 trial(s) available for clopidogrel and Coronary Stenosis
Article | Year |
---|---|
Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment.
Topics: Adult; Aged; Aspirin; Blood Platelets; Catechin; Clopidogrel; Coronary Stenosis; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Republic of Korea; Ticagrelor; Ticlopidine | 2018 |
Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Aged; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
Topics: Aspirin; Blood Coagulation Tests; Clopidogrel; Coronary Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prospective Studies; Registries; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction.
Topics: Aged; Anticoagulants; Clopidogrel; Coronary Angiography; Coronary Stenosis; Drug Therapy, Combination; Early Termination of Clinical Trials; Heparin; Hirudins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Recombinant Proteins; Thiophenes; Ticlopidine; Treatment Outcome | 2014 |
A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Treatment Outcome; Tubulin Modulators | 2014 |
Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.
Topics: Adenosine; Aged; Clopidogrel; Coronary Angiography; Coronary Stenosis; Drug Administration Schedule; Female; Humans; Magnetic Resonance Angiography; Male; Microvessels; Middle Aged; Myocardial Revascularization; Organ Size; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome | 2016 |
Prevalence and Predictors of Early Discontinuation of Dual-Antiplatelet Therapy After Drug-Eluting Stent Implantation in Korean Population.
Topics: Adult; Aged; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prevalence; Republic of Korea; Retrospective Studies; Risk Factors; Ticlopidine; Time Factors; Withholding Treatment; Young Adult | 2016 |
Clopidogrel resistance in Japanese patients scheduled for percutaneous coronary intervention.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cell Adhesion Molecules; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Humans; Male; Microfilament Proteins; Middle Aged; Myocardial Ischemia; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome | 2009 |
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Elective Surgical Procedures; Female; Graft Occlusion, Vascular; Graft Rejection; Graft Survival; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Probability; Prognosis; Survival Rate; Ticlopidine; Treatment Outcome; Vascular Patency | 2009 |
Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy).
Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Embolism; Female; Humans; Incidence; Male; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Saphenous Vein; Survival Rate; Ticlopidine; United States | 2010 |
Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Confidence Intervals; Coronary Stenosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Elective Surgical Procedures; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Predictive Value of Tests; Probability; Prospective Studies; Prosthesis Failure; Risk Assessment; Stents; Survival Analysis; Ticlopidine | 2010 |
Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention.
Topics: Aged; Alleles; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aryldialkylphosphatase; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Adhesion Molecules; Clopidogrel; Coronary Stenosis; Cytochrome P-450 CYP2C19; Female; Gene Dosage; Genetic Association Studies; Genotype; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Ticlopidine; Treatment Outcome | 2011 |
Clinical outcomes of high on-treatment platelet reactivity in Koreans receiving elective percutaneous coronary intervention (from results of the CROSS VERIFY study).
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Stenosis; Elective Surgical Procedures; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Republic of Korea; Risk Factors; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot Genous trial.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Severity of Illness Index; Stents; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2011 |
Prediction of significant left main coronary artery stenosis by the 12-lead electrocardiogram in patients with rest angina pectoris and the withholding of clopidogrel therapy.
Topics: Adult; Aged; Angina, Unstable; Clopidogrel; Coronary Angiography; Coronary Stenosis; Electrocardiography; Female; Humans; Male; Middle Aged; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Ticlopidine; Withholding Treatment | 2003 |
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Death, Sudden; Diabetes Mellitus; Disease-Free Survival; Drug Implants; Female; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Safety; Sirolimus; Stents; Survival Analysis; Ticlopidine; Treatment Outcome | 2004 |
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2004 |
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Double-Blind Method; Drug Implants; Female; Humans; Life Tables; Male; Middle Aged; Myocardial Infarction; Premedication; Sirolimus; Stents; Survival Analysis; Ticlopidine; Treatment Outcome; Ultrasonography | 2004 |
The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prosthesis Implantation; Stents; Ticlopidine; Time Factors; Tunica Intima; Ultrasonography, Interventional | 2004 |
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries.
Topics: Aged; Aspirin; Clopidogrel; Coronary Aneurysm; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Double-Blind Method; Drug Implants; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Incidence; Male; Middle Aged; Randomized Controlled Trials as Topic; Sirolimus; Stents; Ticlopidine; Treatment Outcome | 2004 |
Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Eptifibatide; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Risk Factors; Stents; Ticlopidine | 2005 |
The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting.
Topics: Adenosine Diphosphate; Aged; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Treatment Outcome | 2005 |
Delayed thrombin-induced platelet-fibrin clot generation by clopidogrel: a new dose-related effect demonstrated by thrombelastography in patients undergoing coronary artery stenting.
Topics: Aged; Anticoagulants; Aspirin; Blood Coagulation; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation; Reproducibility of Results; Stents; Thrombelastography; Thrombin; Ticlopidine; Time Factors; Treatment Outcome | 2007 |
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine | 2006 |
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
Topics: Aged; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Death, Sudden, Cardiac; Diabetic Angiopathies; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Failure; Reoperation; Sirolimus; Ticlopidine; Treatment Outcome | 2007 |
Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
Topics: Aspirin; Biomarkers; Blood Vessel Prosthesis Implantation; Cilostazol; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Drug Therapy, Combination; Female; Flow Cytometry; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Revascularization; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Preoperative Care; Radiography; Stents; Tetrazoles; Ticlopidine; Treatment Outcome | 2007 |
Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up.
Topics: Aged; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Stenosis; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors | 2001 |
105 other study(ies) available for clopidogrel and Coronary Stenosis
Article | Year |
---|---|
Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry).
Topics: Aged; Bayes Theorem; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Drug Utilization; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prescriptions; Registries; Retrospective Studies; Severity of Illness Index; Survival Analysis; Ticagrelor; Treatment Outcome; United States | 2019 |
Continuation of Dual Antiplatelet Therapy in a Patient with a Coronary Artery Stent with Dengue Hemorrhagic Fever: A Clinical Conundrum.
Topics: Aspirin; Clopidogrel; Coronary Stenosis; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Severe Dengue | 2020 |
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: when real-life scenarios face the shadows of the evidence-based medicine.
Topics: Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Aspirin; Clinical Decision-Making; Clopidogrel; Coronary Stenosis; Disease Progression; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Assessment; Thrombosis; Treatment Outcome; Warfarin | 2020 |
Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model.
Topics: Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Factor Xa Inhibitors; Graft Occlusion, Vascular; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Swine; Tomography, Optical Coherence | 2022 |
Comparison of the 9-month intra-stent conditions and 2-year clinical outcomes after Resolute zotarolimus-eluting stent implantation between 3-month and standard dual antiplatelet therapy.
Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Hemorrhage; Humans; Japan; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Sirolimus; Thrombosis; Tomography, Optical Coherence | 2018 |
Thrombocytosis as a potential cause of a very late stent thrombosis in the left main coronary artery.
Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Out-of-Hospital Cardiac Arrest; Paclitaxel; Thrombocytosis; Ticlopidine; Withholding Treatment | 2013 |
P2Y12 Receptor Blockade and Myocardial Perfusion.
Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine | 2013 |
[The CHAMPION PHOENIX study].
Topics: Adenosine Monophosphate; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Double-Blind Method; Hemorrhage; Humans; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Stents; Ticlopidine | 2013 |
The relationship between fractional flow reserve, platelet reactivity and platelet leukocyte complexes in stable coronary artery disease.
Topics: Aged; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Female; Fractional Flow Reserve, Myocardial; Humans; Leukocytes; Male; Middle Aged; Myocardial Ischemia; Platelet Activation; Platelet Aggregation Inhibitors; Prognosis; Ticlopidine | 2013 |
Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases.
Topics: Absorbable Implants; Adenosine; Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Treatment Outcome | 2015 |
Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospital Mortality; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Failure; Registries; Retrospective Studies; Severity of Illness Index; Sirolimus; Survival Analysis; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment | 2014 |
Successful treatment of bleeding large duodenal gastrointestinal stromal tumour in a patient under dual antiplatelet therapy after recent drug-eluting coronary stent implantation.
Topics: Aged; Aspirin; Benzamides; Chemotherapy, Adjuvant; Clopidogrel; Coronary Stenosis; Drug-Eluting Stents; Duodenal Neoplasms; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Hemostatic Techniques; Humans; Imatinib Mesylate; Male; Neoadjuvant Therapy; Piperazines; Platelet Aggregation Inhibitors; Pyrimidines; Ticlopidine | 2014 |
Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Diabetes Complications; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine | 2014 |
Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans - a validation study - .
Topics: Adventitia; Aged; Aged, 80 and over; Animals; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Vessels; Disease Progression; Drug-Eluting Stents; Everolimus; Female; Humans; Interferometry; Male; Middle Aged; Neointima; Neovascularization, Physiologic; Platelet Aggregation Inhibitors; Postoperative Period; Prosthesis Implantation; Sirolimus; Stents; Swine; Swine, Miniature; Ticlopidine; Tomography, Optical Coherence; Vasa Vasorum; Vasculitis | 2015 |
Two young women with severe coronary arterial ostial narrowing: A potential subtype of Takayasu arteritis.
Topics: Adult; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Methylprednisolone; Monitoring, Physiologic; Platelet Aggregation Inhibitors; Rare Diseases; Sampling Studies; Takayasu Arteritis; Ticlopidine; Treatment Outcome; Young Adult | 2015 |
Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
Topics: Absorbable Implants; Aged, 80 and over; Anterior Wall Myocardial Infarction; Brachytherapy; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Metals; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Severity of Illness Index; Stents; Ticlopidine; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2015 |
Long-term Outcomes of Medical Therapy Versus Coronary Revascularisation in Patients with Intermediate Stenoses Guided by Pressure Wire.
Topics: Adult; Aged; Aspirin; Clopidogrel; Coronary Stenosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome | 2015 |
Predictors for Side Branch Failure During Provisional Strategy of Coronary Intervention for Bifurcation Lesions (from the Korean Bifurcation Registry).
Topics: Aged; Calcinosis; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Multivariate Analysis; Organ Size; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Registries; Republic of Korea; Risk Factors; Ticlopidine; Treatment Failure | 2016 |
A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery s
Topics: Acute Coronary Syndrome; Aspirin; Cause of Death; Clopidogrel; Coronary Stenosis; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Time Factors; Treatment Outcome | 2017 |
Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Right | 2008 |
Very late stent thrombosis after discontinuation of clopidogrel therapy.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Failure; Radiography; Stents; Ticlopidine; Time Factors | 2008 |
Optimizing clopidogrel therapy before stent implantation: should clinical setting be taken into account?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Severity of Illness Index; Stents; Ticlopidine; Treatment Outcome | 2008 |
Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Animals; Aspirin; Cell Proliferation; Clopidogrel; Collagen; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Hyperplasia; Inflammation Mediators; Metals; P-Selectin; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Swine; Ticlopidine; Time Factors; Tunica Intima | 2008 |
Calcium-channel blockers reduce the antiplatelet effect of clopidogrel.
Topics: Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Case-Control Studies; Cell Adhesion Molecules; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Dihydropyridines; Drug Interactions; Female; Flow Cytometry; Humans; Logistic Models; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Reference Values; Risk Assessment; Sensitivity and Specificity; Statistics, Nonparametric; Ticlopidine; Treatment Outcome | 2008 |
Clopidogrel and calcium-channel antagonists: another drug-drug interaction for the ever-wary clinician?
Topics: Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Drug Interactions; Female; Humans; Male; Platelet Aggregation; Prognosis; Risk Assessment; Ticlopidine; Treatment Outcome | 2008 |
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sirolimus; Tetrazoles; Ticlopidine; Ventricular Fibrillation | 2010 |
Athero-embolic isolated splenic infarction following left cardiac catheterization.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aortic Aneurysm, Abdominal; Aspirin; Atherosclerosis; Cardiac Catheterization; Clopidogrel; Coronary Stenosis; Embolism, Cholesterol; Heparin; Humans; Infarction; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Spleen; Thrombosis; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2009 |
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.
Topics: Aged; Clopidogrel; Coronary Stenosis; Drug Administration Schedule; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome; Victoria | 2009 |
Spontaneous spinal epidural hematoma: an urgent complication of adding clopidogrel to aspirin therapy.
Topics: Aspirin; Clopidogrel; Coronary Stenosis; Decompression, Surgical; Drug Interactions; Hematoma, Epidural, Spinal; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Spinal Cord; Stents; Ticlopidine; Treatment Outcome | 2009 |
Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery.
Topics: Analysis of Variance; Clopidogrel; Cohort Studies; Coronary Angiography; Coronary Artery Bypass; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Emergency Treatment; Female; Follow-Up Studies; Hospital Mortality; Humans; Logistic Models; Male; Multivariate Analysis; Postoperative Complications; Postoperative Hemorrhage; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Ticlopidine | 2010 |
Changes in platelets and anticoagulant protein activity during adenosine-exercise single-photon emission computed tomography stress test.
Topics: Adenosine; Adenosine Diphosphate; Adult; Aged; Antithrombins; Aspirin; beta-Thromboglobulin; Blood Coagulation; Clopidogrel; Coronary Stenosis; Epinephrine; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 4; Protein C; Ticlopidine; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2010 |
Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Stenosis; Diabetes Complications; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome | 2010 |
Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel.
Topics: Aged; Aspirin; Blood Platelets; CD11b Antigen; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Flow Cytometry; Humans; Leukocytes; Monocytes; P-Selectin; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Up-Regulation | 2011 |
Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Stenosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Feasibility Studies; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Republic of Korea; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Plaque distribution in clopidogrel responders and low responders as determined by multislice computed tomography.
Topics: Aged; Calcinosis; Clopidogrel; Coronary Angiography; Coronary Stenosis; Drug Resistance; Female; Germany; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Function Tests; Predictive Value of Tests; Severity of Illness Index; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Clopidogrel Resistance: case reports of CYP2C19 gene variants in suspected coronary stent thrombosis.
Topics: Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Stenosis; Cytochrome P-450 CYP2C19; Drug Resistance; Female; Genotype; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Stents; Thrombosis; Ticlopidine | 2011 |
Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired P2Y12 inhibition by clopidogrel.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Cause of Death; Clopidogrel; Cohort Studies; Coronary Stenosis; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Purinergic P2Y Receptor Antagonists; Reference Values; Renal Insufficiency, Chronic; Risk Assessment; Survival Analysis; Ticlopidine | 2011 |
Feasibility and safety of 7-Fr radial approach for complex PCI.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Feasibility Studies; Female; Femoral Artery; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Radial Artery; Retrospective Studies; Ticlopidine; Ultrasonography, Interventional | 2011 |
A complex case of angulated and bifurcated lesion facilitated by excimer laser coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Humans; Lasers, Excimer; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine | 2011 |
Aborted myocardial infarction in a patient with rapid progression of Wellens syndrome.
Topics: Aspirin; Clopidogrel; Coronary Stenosis; Early Diagnosis; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Syndrome; Ticlopidine | 2012 |
Gene therapy with iNOS enhances regional contractility and reduces delayed contrast enhancement in a model of postischemic congestive heart failure.
Topics: Animals; Anticoagulants; Aspirin; Clopidogrel; Contrast Media; Coronary Angiography; Coronary Stenosis; Disease Models, Animal; Drug Carriers; Female; Fibrosis; Gadolinium; Genes, Reporter; Genes, Synthetic; Genetic Therapy; Heart Failure; Liposomes; Magnetic Resonance Imaging; Male; Myocardial Contraction; Myocardial Ischemia; Nitric Oxide Synthase Type II; Random Allocation; Stents; Sus scrofa; Swine; Ticlopidine; Ventricular Dysfunction, Left | 2011 |
Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention.
Topics: Aged; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Coronary Stenosis; Disease-Free Survival; Drug Interactions; Female; Hospitals, University; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polypharmacy; Proportional Hazards Models; Proton Pump Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome | 2013 |
Simultaneous subacute thrombosis of bare metal coronary stents in two different arteries early after clopidogrel cessation.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Administration Schedule; Electrocardiography; Female; Humans; Medication Adherence; Metals; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Long-term successful percutaneous coronary intervention in factor VII deficiency.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Diabetes Mellitus, Type 2; Factor VII Deficiency; Follow-Up Studies; Humans; Male; Middle Aged; Obesity, Morbid; Platelet Aggregation Inhibitors; Radiography; Risk Assessment; Stents; Thromboembolism; Ticlopidine; Time Factors; Treatment Outcome | 2012 |
Dual antiplatelet therapy after drug-eluting stent implantation: is it time to slacken the reins?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Medication Adherence; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Sirolimus; Ticlopidine; Withholding Treatment | 2012 |
Deliverability of integrity coronary stents in severely tortuous coronary arteries: a preliminary experience.
Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome | 2012 |
Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrel.
Topics: Aged; Aspirin; Brain Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Clopidogrel; Colonic Neoplasms; Coronary Stenosis; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Drug Therapy, Combination; Drug-Eluting Stents; Fatal Outcome; Female; Humans; Lung Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Thiophenes; Ticlopidine; Time Factors | 2013 |
[Off-label use of clopidogrel after coronary stent implantation in Germany: optional or mandatory?].
Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Drug Approval; Drug Costs; Drug Prescriptions; Drug Therapy, Combination; Drugs, Investigational; Financing, Personal; Germany; Humans; National Health Programs; Randomized Controlled Trials as Topic; Stents; Ticlopidine; Treatment Outcome | 2003 |
Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Case-Control Studies; Cell Adhesion Molecules; Chi-Square Distribution; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Female; Flow Cytometry; Humans; Male; Microfilament Proteins; Middle Aged; Monitoring, Physiologic; Phosphoproteins; Pilot Projects; Platelet Aggregation Inhibitors; Premedication; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Stents; Ticlopidine; Treatment Outcome | 2003 |
Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Premedication; Product Surveillance, Postmarketing; Retrospective Studies; Stents; Survival Analysis; Ticlopidine; Treatment Outcome | 2003 |
[Clopidogrel and thrombopenia. A case report].
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Stenosis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Stents; Thrombocytopenia; Ticlopidine | 2003 |
Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: management issues.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Drug Eruptions; Female; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Urticaria | 2004 |
Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura.
Topics: Aged; Angioplasty, Balloon; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Eptifibatide; Humans; Male; Peptides; Platelet Aggregation Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Stents; Ticlopidine | 2004 |
Resistance to antiplatelet drugs: is it real or relevant?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Brachytherapy; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors | 2004 |
Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance?
Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Brachytherapy; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors | 2004 |
Paclitaxel-eluting coronary stents.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Pyridines; Stents; Thrombosis; Ticlopidine | 2004 |
Platelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?
Topics: Aged; Blood Vessel Prosthesis Implantation; Body Mass Index; Body Weight; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Spain; Stents; Ticlopidine; Treatment Outcome; Weights and Measures | 2004 |
Clopidogrel dosing in overweight patients: does one size fit all?
Topics: Blood Vessel Prosthesis Implantation; Body Mass Index; Body Weight; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Humans; Obesity; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2004 |
Multivessel distal sutureless off-pump coronary artery bypass grafting procedure using magnetic connectors.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Coronary Restenosis; Coronary Stenosis; Equipment Design; Humans; Internal Mammary-Coronary Artery Anastomosis; Magnetics; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine | 2004 |
[How does it work? Coronary stent implantation].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2004 |
Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Biomarkers; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Creatine Kinase; Creatine Kinase, MB Form; Disease-Free Survival; Equipment Design; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Isoenzymes; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; New York; Platelet Aggregation Inhibitors; Postoperative Complications; Severity of Illness Index; Stents; Ticlopidine; Treatment Outcome; Troponin I | 2004 |
Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Blood Platelets; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Stenosis; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Pyrroles; Stents; Ticlopidine | 2004 |
Impaired platelet responses to clopidogrel and ticlopidine in a patient with recurrent coronary stent stenosis.
Topics: Adenosine Diphosphate; Blood Platelets; Clopidogrel; Coronary Stenosis; Cyclic AMP; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine | 2004 |
Subacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpura.
Topics: Aged; Angina, Unstable; Blood Vessel Prosthesis; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Humans; Male; Platelet Aggregation Inhibitors; Prosthesis Failure; Purpura, Thrombotic Thrombocytopenic; Recurrence; Stents; Ticlopidine | 2005 |
Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Eptifibatide; Hemorrhage; Length of Stay; Membrane Proteins; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Risk Factors; Stents; Thrombophilia; Ticlopidine | 2005 |
[Exercise-induced left arm pain and thrombocytosis].
Topics: Angioplasty, Balloon, Coronary; Bone Marrow Examination; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Stenosis; Coronary Thrombosis; Diagnosis, Differential; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Risk Factors; Smoking; Stents; Thrombocythemia, Essential; Ticlopidine | 2005 |
Very late thrombosis after implantation of sirolimus eluting stent.
Topics: Adult; Aspirin; Blood Vessel Prosthesis; Catheterization; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Implants; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Prosthesis Failure; Retreatment; Sirolimus; Stents; Ticlopidine; Time Factors | 2005 |
Technique of left main stenting is dependent on lesion location and distal branch protection.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; North Carolina; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Stroke Volume; Ticlopidine; Treatment Outcome | 2005 |
Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era.
Topics: Acute Disease; Anticoagulants; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pyridines; Retrospective Studies; Stents; Thrombolytic Therapy; Ticlopidine; Treatment Outcome | 2005 |
Intracranial bleeding associated with clopidogrel.
Topics: Aged; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Clopidogrel; Coronary Stenosis; Humans; Hypertension; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Tomography, X-Ray Computed | 2005 |
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
Topics: Abciximab; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Inflammation; Male; Middle Aged; Postoperative Period; Premedication; Stents; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Does clopidogrel improve the long-term outcome after coronary artery bypass surgery?
Topics: Clopidogrel; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Treatment Outcome | 2005 |
What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation?
Topics: Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome | 2005 |
Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study.
Topics: Aged; Clopidogrel; Coronary Stenosis; Female; Humans; Male; Middle Aged; Platelet Activation; Stents; Thrombosis; Ticlopidine | 2005 |
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Disease; Coronary Restenosis; Coronary Stenosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Implants; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Internet; Male; Middle Aged; Myocardial Infarction; Product Surveillance, Postmarketing; Registries; Risk Factors; Sirolimus; Stents; Thrombosis; Ticlopidine; United States | 2006 |
Suspected clopidogrel resistance in a patient with acute stent thrombosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Drug Resistance; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Prosthesis Failure; Recurrence; Risk Assessment; Stents; Ticlopidine; Treatment Outcome | 2006 |
Combined aspirin and clopidogrel resistance associated with recurrent coronary stent thrombosis.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Female; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine; Treatment Failure | 2006 |
Spontaneous or clopidogrel related recanalisation of a coronary artery.
Topics: Clopidogrel; Coronary Angiography; Coronary Stenosis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice.
Topics: Aspirin; Brachytherapy; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2007 |
Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation.
Topics: Animals; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Stenosis; Cyclooxygenase Inhibitors; Isoxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Risk Factors; Shear Strength; Thrombosis; Ticlopidine | 2006 |
Case report: An unusual complication of clopidogrel.
Topics: Clopidogrel; Coronary Stenosis; Hallucinations; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine | 2007 |
Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration.
Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Humans; Male; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine | 2006 |
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Combined Modality Therapy; Consensus Development Conferences as Topic; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stents; Stroke; Ticlopidine; Warfarin | 2006 |
Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried?
Topics: Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stents; Ticlopidine | 2006 |
Management of a spontaneous renal capsule hematoma following cardiac catheterization involving use of a platelet glycoprotein IIb/IIIa inhibitor: a case report.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Catheterization; Clopidogrel; Coronary Stenosis; Embolization, Therapeutic; Female; Hematoma; Humans; Immunoglobulin Fab Fragments; Kidney Diseases; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Radiography, Interventional; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
A case report of simultaneous thrombosis of two coronary artery stents in association with clopidogrel resistance.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine | 2007 |
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Diabetes Mellitus; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Renal Insufficiency; Risk Factors; Sirolimus; Stents; Ticlopidine; Treatment Outcome | 2007 |
Confined late stent thrombosis following clopidogrel withdrawal in a patient with multi-segment sirolimus-eluting stent implants.
Topics: Abciximab; Aged; Angioplasty, Balloon; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Coronary Thrombosis; Heparin; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine | 2007 |
Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Disease Progression; Drug Hypersensitivity; Drug Therapy, Combination; Exanthema; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tubulin Modulators; Urticaria | 2007 |
[Suspected clopidogrel resistance associated with recurrent coronary stent thrombosis--a case report].
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Electrocardiography; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine | 2007 |
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Confidence Intervals; Coronary Angiography; Coronary Stenosis; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Probability; Risk Factors; Ticlopidine; Treatment Outcome | 2007 |
Relationship between microvascular resistance and perfusion in patients with reperfused acute myocardial infarction.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Female; Health Status Indicators; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Perfusion; Prospective Studies; Severity of Illness Index; Ticlopidine | 2007 |
Late coronary stent thrombosis complicating urologic surgery.
Topics: Aged; Clopidogrel; Coronary Stenosis; Drug-Eluting Stents; Fatal Outcome; Humans; Immunosuppressive Agents; Lymph Node Excision; Male; Paclitaxel; Platelet Aggregation Inhibitors; Prostatic Neoplasms; Thrombosis; Ticlopidine; Withholding Treatment | 2008 |
Coronary artery in-stent stenosis persists despite inhibition of the von Willebrand factor--collagen interaction in baboons.
Topics: Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Aspirin; Clopidogrel; Collagen; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Male; Papio ursinus; Platelet Adhesiveness; Stents; Ticlopidine; Time Factors; Tunica Intima; von Willebrand Factor | 2007 |
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Topics: Acute Coronary Syndrome; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Chronic Disease; Clopidogrel; Contraindications; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Coronary Stenosis; Drug-Eluting Stents; Electrocardiography; Evidence-Based Medicine; Exercise Test; Humans; Kidney Diseases; Myocardial Infarction; Nomograms; Patient Selection; Platelet Aggregation Inhibitors; Prognosis; Radionuclide Ventriculography; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Stents; Stroke Volume; Thrombolytic Therapy; Ticlopidine | 2008 |
Successful emergent surgical revascularization and retrieval of entrapped drug eluting stent.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Bypass; Coronary Stenosis; Device Removal; Drug-Eluting Stents; Emergency Medical Services; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retreatment; Ticlopidine; Treatment Refusal | 2008 |
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.
Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Epidemiologic Methods; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prognosis; Ticlopidine | 2008 |
Switching thienopyridines: hypothetical versus real risks.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome | 2008 |
Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Premedication; Prospective Studies; Recurrence; Registries; Retreatment; Stents; Thrombosis; Ticlopidine | 2008 |
Resistance to what, does it matter? How do we study it?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Point-of-Care Systems; Ticlopidine | 2008 |
[Influence of statins on the antiplatelet effect of clopidogrel and on cardiovascular outcome in patients after coronary intervention].
Topics: Atorvastatin; Clopidogrel; Coronary Disease; Coronary Stenosis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Stents; Ticlopidine | 2008 |
Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Stenosis; Cytochrome P-450 CYP3A; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Stents; Ticlopidine | 2008 |
Edge stenosis after intracoronary radiotherapy: angiographic, intravascular, and histological findings.
Topics: Aged; Angioplasty, Balloon, Laser-Assisted; Anticoagulants; Aspirin; Brachytherapy; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Humans; Hyperlipidemias; Hypertension; Iridium Radioisotopes; Male; Myocardial Revascularization; Recurrence; Reoperation; Stents; Ticlopidine | 2001 |
Coronary stent thrombosis: insights from the porcine coronary stent model.
Topics: Animals; Anticoagulants; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Heparin; Humans; Models, Animal; Myocardial Infarction; Stents; Swine; Ticlopidine | 2001 |
Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries.
Topics: Animals; Aspirin; Blood Coagulation Tests; Bradykinin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Evaluation; Metabolic Clearance Rate; Peptide Fragments; Platelet Function Tests; Regional Blood Flow; Therapeutic Equivalency; Ticlopidine; Time Factors | 2001 |